Class information for:
Level 1: ATOVAQUONE//TOXOPLASMIC ENCEPHALITIS//TOXOPLASMA ENCEPHALITIS

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
14564 695 30.8 70%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
1620 6498 PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ATOVAQUONE Author keyword 8 23% 4% 31
2 TOXOPLASMIC ENCEPHALITIS Author keyword 7 36% 2% 15
3 TOXOPLASMA ENCEPHALITIS Author keyword 5 47% 1% 8
4 AEROSOLIZED PENTAMIDINE Author keyword 5 37% 1% 10
5 PNEUMOCYSTIS CARINII PNEUMONIA Author keyword 4 11% 5% 35
6 AEROSOL PENTAMIDINE Author keyword 2 67% 0% 2
7 DISCONTINUATION OF PROPHYLAXIS Author keyword 2 67% 0% 2
8 TOXOPLASMA SEROLOGY Author keyword 2 67% 0% 2
9 ANTI TOXOPLASMA GONDII ACTIVITY Author keyword 1 50% 0% 2
10 CRB TOXOPLASMA Address 1 100% 0% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 ATOVAQUONE 8 23% 4% 31 Search ATOVAQUONE Search ATOVAQUONE
2 TOXOPLASMIC ENCEPHALITIS 7 36% 2% 15 Search TOXOPLASMIC+ENCEPHALITIS Search TOXOPLASMIC+ENCEPHALITIS
3 TOXOPLASMA ENCEPHALITIS 5 47% 1% 8 Search TOXOPLASMA+ENCEPHALITIS Search TOXOPLASMA+ENCEPHALITIS
4 AEROSOLIZED PENTAMIDINE 5 37% 1% 10 Search AEROSOLIZED+PENTAMIDINE Search AEROSOLIZED+PENTAMIDINE
5 PNEUMOCYSTIS CARINII PNEUMONIA 4 11% 5% 35 Search PNEUMOCYSTIS+CARINII+PNEUMONIA Search PNEUMOCYSTIS+CARINII+PNEUMONIA
6 AEROSOL PENTAMIDINE 2 67% 0% 2 Search AEROSOL+PENTAMIDINE Search AEROSOL+PENTAMIDINE
7 DISCONTINUATION OF PROPHYLAXIS 2 67% 0% 2 Search DISCONTINUATION+OF+PROPHYLAXIS Search DISCONTINUATION+OF+PROPHYLAXIS
8 TOXOPLASMA SEROLOGY 2 67% 0% 2 Search TOXOPLASMA+SEROLOGY Search TOXOPLASMA+SEROLOGY
9 ANTI TOXOPLASMA GONDII ACTIVITY 1 50% 0% 2 Search ANTI+TOXOPLASMA+GONDII+ACTIVITY Search ANTI+TOXOPLASMA+GONDII+ACTIVITY
10 WITHDRAWAL OF PROPHYLAXIS 1 100% 0% 2 Search WITHDRAWAL+OF+PROPHYLAXIS Search WITHDRAWAL+OF+PROPHYLAXIS

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 AEROSOLIZED PENTAMIDINE 27 26% 13% 90
2 DAPSONE PYRIMETHAMINE 21 57% 4% 25
3 TOXOPLASMIC ENCEPHALITIS 16 33% 6% 40
4 NERVOUS SYSTEM TOXOPLASMOSIS 15 47% 3% 24
5 SECONDARY PROPHYLAXIS 13 21% 8% 54
6 HYDROXYNAPHTHOQUINONE 566C80 11 57% 2% 13
7 WEEKLY DAPSONE PYRIMETHAMINE 11 100% 1% 6
8 CYST FORM 9 64% 1% 9
9 566C80 9 27% 4% 28
10 DOSE TRIMETHOPRIM SULFAMETHOXAZOLE 9 83% 1% 5

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 - Recommendations of the US Public Health Service and the Infectious Diseases Society of America 2002 125 106 27%
Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients 2013 4 34 56%
Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/mu L and Virologic Suppression: A Systematic Review 2011 6 33 61%
Drug therapy: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. 2000 130 75 27%
Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: A review 1998 49 50 46%
Treatment regimens for patients with toxoplasmic encephalitis 1996 30 55 71%
TOXOPLASMOSIS IN HIV/AIDS: A LIVING LEGACY 2009 17 119 32%
Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings) 2006 7 18 61%
PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION 1994 113 126 30%
ATOVAQUONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN OPPORTUNISTIC INFECTIONS 1995 35 42 40%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 CRB TOXOPLASMA 1 100% 0.3% 2
2 CLIN CRIT CARE MED 1 40% 0.3% 2
3 CNR TOXOPLASMOSE 1 33% 0.3% 2
4 ABT INFEKTIONSKRANKHEITEN SPITALHYG 1 50% 0.1% 1
5 AIDS AIDS CLIN TRIALS GRP 1 50% 0.1% 1
6 BIOL OURCE TOXOPLASMA 1 50% 0.1% 1
7 COMPREHENS INFECT DIS ULM 1 50% 0.1% 1
8 DIRECC INVEST OPERAT 1 50% 0.1% 1
9 GRP FISIOL MOL 1 50% 0.1% 1
10 HOSP PREVENT MED INFECT DIS 1 50% 0.1% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000205537 CONGENITAL TOXOPLASMOSIS//TOXOPLASMOSIS//OCULAR TOXOPLASMOSIS
2 0.0000188916 PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII//PNEUMOCYSTIS PNEUMONIA
3 0.0000120054 APICOPLAST//41H QUINOLONES//ORGANELLAR TARGETING
4 0.0000115190 HPPK//DIHYDROPTEROATE SYNTHASE//PYROPHOSPHOKINASE
5 0.0000114844 PULMONARY KAPOSIS SARCOMA//EXTRAPULMONARY PNEUMOCYSTOSIS//PNEUMOCYSTIS CARINII PNEUMONIA
6 0.0000105644 RIFABUTIN//KRM 1648//RIFALAZIL
7 0.0000096197 VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS
8 0.0000087144 FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM
9 0.0000083307 TOXOPLASMA GONDII//TOXOPLASMA//SAG1
10 0.0000082354 PENTAMIDINE//DIAMIDINES//AROMATIC DIAMIDINES